NHS England has named ambient voice technology and AI triage as the priority spending areas for its £10 billion digital investment, with regional trusts expected to adopt ambient voice tools starting in April 2026.
ARPA-H has awarded the University of Vermont up to $38 million to build AI digital twins that model a critically ill patient's immune response in real time, with a goal of cutting ICU stays by at least 25 percent.
The UK's Information Commissioner's Office opened a formal investigation on February 3, 2026 into X.AI and X over whether Grok unlawfully processed personal data to generate non-consensual sexualised images, including of children.
Florida Attorney General James Uthmeier sued OpenAI and Sam Altman personally on June 2, 2026, seeking a court order to stop ChatGPT from collecting data from children under 13 without parental consent.
Kentucky Attorney General Russell Coleman sued Character.AI on January 12, 2026 under the state's brand-new Consumer Data Protection Act, alleging the chatbot collected children's data without parental consent and used it to train its AI models.
Voice-biomarker startup Kintsugi shut down in February 2026 after spending $30 million over seven years, including roughly $16 million on FDA pre-submission work, and never filed its De Novo application despite a pivotal study showing its AI matched clinical depression screening accuracy.
The FDA granted Breakthrough Device Designation in March 2026 to PathAI's PathAssist Derm, an AI tool meant to help pathologists on ambiguous skin biopsies — a category where studies show diagnostic concordance between pathologists falls below 50%.
Vanderbilt University Medical Center is running the VTE-AI randomized trial, one of the first studies testing whether an AI-driven electronic health record alert — built from 132,330 patient encounters — can cut hospital-acquired blood clots across both urban and rural hospitals.
Minnesota's 30-day warning period for privacy violations expired January 31, giving the attorney general free rein to sue companies over misuse of residents' health data, which can draw penalties up to $7,500 per violation.
Medtronic's FDA-cleared Nellcor pulse oximetry system with its new Nell-EQ processor is designed to deliver accurate oxygen readings across all skin tones, addressing a bias problem that drew intense scrutiny during the COVID-19 pandemic.